HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrew D Goodman Selected Research

Andrew D Goodman Research Topics

Disease

19Multiple Sclerosis
10/2022 - 05/2003
3Atrophy
01/2021 - 01/2021
2Disease Progression
01/2022 - 07/2014
2Relapsing-Remitting Multiple Sclerosis
11/2014 - 04/2014
2Fatigue
10/2003 - 03/2002
1Ganglion Cysts (Ganglion)
01/2021
1Bradycardia
12/2019
1Chronic Disease (Chronic Diseases)
04/2016
1Pain (Aches)
04/2016
1Progressive Multifocal Leukoencephalopathy
09/2010
1Optic Neuritis (Retrobulbar Neuritis)
04/2008
1Transverse Myelitis (Necrotizing Myelitis)
04/2008

Drug/Important Bio-Agent (IBA)

5ibudilastIBA
11/2021 - 10/2016
54-Aminopyridine (4 Aminopyridine)FDA Link
12/2015 - 10/2010
3TabletsIBA
12/2015 - 01/2014
2Amantadine (Aman)FDA LinkGeneric
01/2022 - 03/2002
2Biomarkers (Surrogate Marker)IBA
11/2021 - 07/2014
2Natalizumab (Tysabri)FDA Link
11/2014 - 09/2010
1Glatiramer Acetate (Copaxone)FDA Link
10/2022
1siponimodIBA
12/2019
1Interferon beta-1aFDA Link
11/2014
1Neutralizing AntibodiesIBA
04/2014
1AntibodiesIBA
04/2014
1InterferonsIBA
04/2014
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2013
1DNA (Deoxyribonucleic Acid)IBA
09/2010
1Memantine (Namenda)FDA Link
02/2010
1Immunoglobulin G (IgG)IBA
04/2008
1AntigensIBA
05/2003
1Pemoline (Cylert)FDA Link
03/2002

Therapy/Procedure

3Therapeutics
04/2016 - 03/2002
1Aftercare (After-Treatment)
01/2022
1Immunomodulation
05/2011
1Immunotherapy
04/2008